Abstract
Since the days of the COVID pandemic, the Drug Enforcement Administration (DEA) has allowed buprenorphine to be prescribed by telephone when used to treat opioid use disorder. During the pandemic, it allowed folks to continue to receive this lifesaving medicine and made it possible for many more to become engaged in care! It has worked, and all the federal administrations since March 2020 have allowed telephonic initiation to continue. That will end after more than six years, on December 31, 2026.
Keywords
- Opioid Use Disorder Treatment
- buprenorphine
- opioid use disorder
- Drug Enforcement Administration
- COVID-19 pandemic
- medication-assisted treatment
- Open access
Source
Published in Alcoholism & Drug Abuse Weekly. The abstract is shown as published and remains the work of its authors; read the full article at the source.
Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.